{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:02:55Z","timestamp":1789736575154,"version":"4.0.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12771-1","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:48:03Z","timestamp":1789728483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR\u2013Cas9 genome editing: technological advances, delivery strategies and precision engineering of primary cells for therapeutic application in genetic disorders and diabetes mellitus"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0600-2893","authenticated-orcid":false,"given":"Md Nur","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Mahmudul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sm Faysal","family":"Bellah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Morsed","family":"Zaman Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-5212","authenticated-orcid":false,"given":"Md Shafayat","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"1","key":"12771_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s44162-025-00099-6","volume":"4","author":"A Chaudhary","year":"2025","unstructured":"Chaudhary A, Kumar V (2025) Rare diseases: a comprehensive literature review and future directions. J Rare Dis 4(1):33","journal-title":"J Rare Dis"},{"issue":"6405","key":"12771_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.aat5011","volume":"361","author":"GJ Knott","year":"2018","unstructured":"Knott GJ, Doudna JA (2018) CRISPR-Cas guides the future of genetic engineering. Science 361(6405):866\u2013869","journal-title":"Science"},{"issue":"6096","key":"12771_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821","journal-title":"Science"},{"issue":"6","key":"12771_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","volume":"13","author":"Y Wu","year":"2013","unstructured":"Wu Y, Liang D, Wang Y, Bai M, Tang W, Bao S, Yan Z, Li D, Li J (2013) Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 13(6):659\u2013662","journal-title":"Cell Stem Cell"},{"issue":"6","key":"12771_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","volume":"13","author":"G Schwank","year":"2013","unstructured":"Schwank G, Koo B-K, Sasselli V, Dekkers JF, Heo I, Demircan T, Sasaki N, Boymans S, Cuppen E, Van Der Ent CK (2013) Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13(6):653\u2013658","journal-title":"Cell Stem Cell"},{"issue":"5","key":"12771_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","volume":"26","author":"Y Lu","year":"2020","unstructured":"Lu Y, Xue J, Deng T, Zhou X, Yu K, Deng L, Huang M, Yi X, Liang M, Wang Y (2020) Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. Nat Med 26(5):732\u2013740","journal-title":"Nat Med"},{"key":"12771_CR7","doi-asserted-by":"publisher","first-page":"1888734","DOI":"10.3389\/fonc.2026.1888734","volume":"16","author":"CX Ng","year":"2026","unstructured":"Ng CX, Mustafa S, Yap XY, Lee SH (2026) CRISPR\/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions. Front Oncol 16:1888734","journal-title":"Front Oncol"},{"issue":"7","key":"12771_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.22270\/jddt.v16i7.7825","volume":"16","author":"S Jena","year":"2026","unstructured":"Jena S, Lenka S, Patra C, Rau SK (2026) Therapeutic Advancement in Cardiovascular Disorders: Molecular Mechanisms, Emerging Targets and Translational Perspectives. J Drug Delivery Ther 16(7):170","journal-title":"J Drug Delivery Ther"},{"issue":"7866","key":"12771_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","volume":"595","author":"GA Newby","year":"2021","unstructured":"Newby GA, Yen JS, Woodard KJ, Mayuranathan T, Lazzarotto CR, Li Y, Sheppard-Tillman H, Porter SN, Yao Y, Mayberry K (2021) Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature 595(7866):295\u2013302","journal-title":"Nature"},{"issue":"6","key":"12771_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/17435889.2026.2629031","volume":"21","author":"Y Miao","year":"2026","unstructured":"Miao Y, Li C, Su Y, Peng T, Wang J, Liu S, Ma C, Li L, Wang Y (2026) The application of CRISPR-Cas9 system in brain diseases. Nanomedicine 21(6):899\u2013920","journal-title":"Nanomedicine"},{"issue":"6","key":"12771_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41580-023-00697-6","volume":"25","author":"L Villiger","year":"2024","unstructured":"Villiger L, Joung J, Koblan L, Weissman J, Abudayyeh OO, Gootenberg JS (2024) CRISPR technologies for genome, epigenome and transcriptome editing. Nat Rev Mol Cell Biol 25(6):464\u2013487","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"12771_CR12","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281\u20132308","journal-title":"Nat Protoc"},{"issue":"6213","key":"12771_CR13","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096","journal-title":"Science"},{"issue":"6","key":"12771_CR14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262\u20131278","journal-title":"Cell"},{"key":"12771_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.addr.2020.10.014","volume":"168","author":"Q Chen","year":"2021","unstructured":"Chen Q, Zhang Y, Yin H (2021) Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing. Adv Drug Deliv Rev 168:246\u2013258","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"12771_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nbt.3290","volume":"33","author":"A Hendel","year":"2015","unstructured":"Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33(9):985\u2013989","journal-title":"Nat Biotechnol"},{"issue":"51","key":"12771_CR17","doi-asserted-by":"publisher","first-page":"E7110","DOI":"10.1073\/pnas.1520883112","volume":"112","author":"M Rahdar","year":"2015","unstructured":"Rahdar M, McMahon MA, Prakash TP, Swayze EE, Bennett CF, Cleveland DW (2015) Synthetic CRISPR RNA-Cas9\u2013guided genome editing in human cells. Proc Natl Acad Sci 112(51):E7110\u2013E7117","journal-title":"Proc Natl Acad Sci"},{"issue":"7340","key":"12771_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature09886","volume":"471","author":"E Deltcheva","year":"2011","unstructured":"Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471(7340):602\u2013607","journal-title":"Nature"},{"issue":"12","key":"12771_CR19","doi-asserted-by":"publisher","first-page":"e0226107","DOI":"10.1371\/journal.pone.0226107","volume":"14","author":"AW Matson","year":"2019","unstructured":"Matson AW, Hosny N, Swanson ZA, Hering BJ, Burlak C (2019) Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR\/Cas9 gene editing system. PLoS ONE 14(12):e0226107","journal-title":"PLoS ONE"},{"issue":"3","key":"12771_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.2808","volume":"32","author":"Y Fu","year":"2014","unstructured":"Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32(3):279\u2013284","journal-title":"Nat Biotechnol"},{"issue":"1","key":"12771_CR21","doi-asserted-by":"publisher","first-page":"28566","DOI":"10.1038\/srep28566","volume":"6","author":"J-P Zhang","year":"2016","unstructured":"Zhang J-P, Li X-L, Neises A, Chen W, Hu L-P, Ji G-Z, Yu J-Y, Xu J, Yuan W-P, Cheng T (2016) Different effects of sgRNA length on CRISPR-mediated gene knockout efficiency. Sci Rep 6(1):28566","journal-title":"Sci Rep"},{"issue":"7","key":"12771_CR22","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","volume":"155","author":"B Chen","year":"2013","unstructured":"Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li G-W, Park J, Blackburn EH, Weissman JS, Qi LS (2013) Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system. Cell 155(7):1479\u20131491","journal-title":"Cell"},{"issue":"3","key":"12771_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nchembio.2559","volume":"14","author":"H Yin","year":"2018","unstructured":"Yin H, Song C-Q, Suresh S, Kwan S-Y, Wu Q, Walsh S, Ding J, Bogorad RL, Zhu LJ, Wolfe SA (2018) Partial DNA-guided Cas9 enables genome editing with reduced off-target activity. Nat Chem Biol 14(3):311\u2013316","journal-title":"Nat Chem Biol"},{"issue":"1","key":"12771_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrm.2015.2","volume":"17","author":"AA Dominguez","year":"2016","unstructured":"Dominguez AA, Lim WA, Qi LS (2016) Beyond editing: repurposing CRISPR\u2013Cas9 for precision genome regulation and interrogation. Nat Rev Mol Cell Biol 17(1):5\u201315","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6121","key":"12771_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339(6121):819\u2013823","journal-title":"Science"},{"issue":"1","key":"12771_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-biochem-013118-111730","volume":"88","author":"D Kim","year":"2019","unstructured":"Kim D, Luk K, Wolfe SA, Kim J-S (2019) Evaluating and enhancing target specificity of gene-editing nucleases and deaminases. Annu Rev Biochem 88(1):191\u2013220","journal-title":"Annu Rev Biochem"},{"issue":"7587","key":"12771_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK (2016) High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529(7587):490\u2013495","journal-title":"Nature"},{"issue":"7676","key":"12771_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature24268","volume":"550","author":"JS Chen","year":"2017","unstructured":"Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA (2017) Enhanced proofreading governs CRISPR\u2013Cas9 targeting accuracy. Nature 550(7676):407\u2013410","journal-title":"Nature"},{"issue":"9","key":"12771_CR29","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.celrep.2020.02.010","volume":"30","author":"M Legut","year":"2020","unstructured":"Legut M, Daniloski Z, Xue X, McKenzie D, Guo X, Wessels H-H, Sanjana NE (2020) High-throughput screens of PAM-flexible Cas9 variants for gene knockout and transcriptional modulation. Cell Rep 30(9):2859\u20132868 e2855","journal-title":"Cell Rep"},{"issue":"1","key":"12771_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s42003-019-0627-8","volume":"2","author":"A Ikeda","year":"2019","unstructured":"Ikeda A, Fujii W, Sugiura K, Naito K (2019) High-fidelity endonuclease variant HypaCas9 facilitates accurate allele-specific gene modification in mouse zygotes. Commun biology 2(1):371","journal-title":"Commun biology"},{"issue":"3","key":"12771_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nbt.4066","volume":"36","author":"A Casini","year":"2018","unstructured":"Casini A, Olivieri M, Petris G, Montagna C, Reginato G, Maule G, Lorenzin F, Prandi D, Romanel A, Demichelis F (2018) A highly specific SpCas9 variant is identified by in vivo screening in yeast. Nat Biotechnol 36(3):265\u2013271","journal-title":"Nat Biotechnol"},{"issue":"10","key":"12771_CR32","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41587-020-0517-0","volume":"38","author":"P Chatterjee","year":"2020","unstructured":"Chatterjee P, Jakimo N, Lee J, Amrani N, Rodr\u00edguez T, Koseki SR, Tysinger E, Qing R, Hao S, Sontheimer EJ (2020) An engineered ScCas9 with broad PAM range and high specificity and activity. Nat Biotechnol 38(10):1154\u20131158","journal-title":"Nat Biotechnol"},{"issue":"7","key":"12771_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41434-022-00319-4","volume":"29","author":"J Lv","year":"2022","unstructured":"Lv J, Xi H, Lv X, Zhou Y, Wang J, Chen H, Yan T, Jin J, Zhao J, Gu F (2022) Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better? Gene Ther 29(7):458\u2013463","journal-title":"Gene Ther"},{"issue":"1","key":"12771_CR34","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-018-06129-w","volume":"9","author":"S Bin Moon","year":"2018","unstructured":"Bin Moon S, Lee JM, Kang JG, Lee N-E, Ha D-I, Kim DY, Kim SH, Yoo K, Kim D, Ko J-H (2018) Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3\u2032-overhang. Nat Commun 9(1):3651","journal-title":"Nat Commun"},{"issue":"1","key":"12771_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13578-019-0298-7","volume":"9","author":"F Safari","year":"2019","unstructured":"Safari F, Zare K, Negahdaripour M, Barekati-Mowahed M, Ghasemi Y (2019) CRISPR Cpf1 proteins: structure, function and implications for genome editing. Cell bioscience 9(1):36","journal-title":"Cell bioscience"},{"issue":"6366","key":"12771_CR36","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1126\/science.aaq0180","volume":"358","author":"DB Cox","year":"2017","unstructured":"Cox DB, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, Zhang F (2017) RNA editing with CRISPR-Cas13. Science 358(6366):1019\u20131027","journal-title":"Science"},{"issue":"6","key":"12771_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s12033-022-00639-1","volume":"65","author":"A Saber Sichani","year":"2023","unstructured":"Saber Sichani A, Ranjbar M, Baneshi M, Torabi Zadeh F, Fallahi J (2023) A review on advanced CRISPR-based genome-editing tools: base editing and prime editing. Mol Biotechnol 65(6):849\u2013860","journal-title":"Mol Biotechnol"},{"issue":"7603","key":"12771_CR38","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533(7603):420\u2013424","journal-title":"Nature"},{"issue":"17","key":"12771_CR39","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.3390\/ijms21176240","volume":"21","author":"A Kantor","year":"2020","unstructured":"Kantor A, McClements ME, MacLaren RE (2020) CRISPR-Cas9 DNA base-editing and prime-editing. Int J Mol Sci 21(17):6240","journal-title":"Int J Mol Sci"},{"issue":"9","key":"12771_CR40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan LW, Doman JL, Wilson C, Levy JM, Tay T, Newby GA, Maianti JP, Raguram A, Liu DR (2018) Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol 36(9):843\u2013846","journal-title":"Nat Biotechnol"},{"issue":"9","key":"12771_CR41","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt.4194","volume":"36","author":"MP Zafra","year":"2018","unstructured":"Zafra MP, Schatoff EM, Katti A, Foronda M, Breinig M, Schweitzer AY, Simon A, Han T, Goswami S, Montgomery E (2018) Optimized base editors enable efficient editing in cells, organoids and mice. Nat Biotechnol 36(9):888\u2013893","journal-title":"Nat Biotechnol"},{"issue":"9","key":"12771_CR42","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41587-019-0193-0","volume":"37","author":"BW Thuronyi","year":"2019","unstructured":"Thuronyi BW, Koblan LW, Levy JM, Yeh W-H, Zheng C, Newby GA, Wilson C, Bhaumik M, Shubina-Oleinik O, Holt JR (2019) Continuous evolution of base editors with expanded target compatibility and improved activity. Nat Biotechnol 37(9):1070\u20131079","journal-title":"Nat Biotechnol"},{"issue":"4","key":"12771_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nbt.4102","volume":"36","author":"X Li","year":"2018","unstructured":"Li X, Wang Y, Liu Y, Yang B, Wang X, Wei J, Lu Z, Zhang Y, Wu J, Huang X (2018) Base editing with a Cpf1\u2013cytidine deaminase fusion. Nat Biotechnol 36(4):324\u2013327","journal-title":"Nat Biotechnol"},{"issue":"10","key":"12771_CR44","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/cr.2017.111","volume":"27","author":"L Wang","year":"2017","unstructured":"Wang L, Xue W, Yan L, Li X, Wei J, Chen M, Wu J, Yang B, Yang L, Chen J (2017) Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor. Cell Res 27(10):1289\u20131292","journal-title":"Cell Res"},{"issue":"7681","key":"12771_CR45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A\u2022 T to G\u2022 C in genomic DNA without DNA cleavage. Nature 551(7681):464\u2013471","journal-title":"Nature"},{"issue":"7","key":"12771_CR46","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","volume":"38","author":"NM Gaudelli","year":"2020","unstructured":"Gaudelli NM, Lam DK, Rees HA, Sol\u00e1-Esteves NM, Barrera LA, Born DA, Edwards A, Gehrke JM, Lee S-J, Liquori AJ (2020) Directed evolution of adenine base editors with increased activity and therapeutic application. Nat Biotechnol 38(7):892\u2013900","journal-title":"Nat Biotechnol"},{"issue":"7","key":"12771_CR47","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter MF, Zhao KT, Eton E, Lapinaite A, Newby GA, Thuronyi BW, Wilson C, Koblan LW, Zeng J, Bauer DE (2020) Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat Biotechnol 38(7):883\u2013891","journal-title":"Nat Biotechnol"},{"issue":"1","key":"12771_CR48","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s41467-021-22519-z","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Yu W, Huang S, Wu S, Li L, Zhou J, Cao Y, Huang X, Qiao Y (2021) Structure-guided engineering of adenine base editor with minimized RNA off-targeting activity. Nat Commun 12(1):2287","journal-title":"Nat Commun"},{"issue":"7","key":"12771_CR49","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41587-020-0527-y","volume":"38","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhu B, Chen L, Xie L, Yu W, Wang Y, Li L, Yin S, Yang L, Hu H (2020) Dual base editor catalyzes both cytosine and adenine base conversions in human cells. Nat Biotechnol 38(7):856\u2013860","journal-title":"Nat Biotechnol"},{"issue":"7785","key":"12771_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576(7785):149\u2013157","journal-title":"Nature"},{"issue":"3","key":"12771_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","volume":"24","author":"PJ Chen","year":"2023","unstructured":"Chen PJ, Liu DR (2023) Prime editing for precise and highly versatile genome manipulation. Nat Rev Genet 24(3):161\u2013177","journal-title":"Nat Rev Genet"},{"issue":"7","key":"12771_CR52","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41434-021-00263-9","volume":"28","author":"J Scholefield","year":"2021","unstructured":"Scholefield J, Harrison PT (2021) Prime editing\u2013an update on the field. Gene Ther 28(7):396\u2013401","journal-title":"Gene Ther"},{"issue":"4","key":"12771_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tcb.2020.01.004","volume":"30","author":"M Marzec","year":"2020","unstructured":"Marzec M, Br\u0105szewska-Zalewska A, Hensel G (2020) Prime editing: a new way for genome editing. Trends Cell Biol 30(4):257\u2013259","journal-title":"Trends Cell Biol"},{"issue":"22","key":"12771_CR54","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen P-F, Chen C, Nelson JW, Newby GA, Sahin M (2021) Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 184(22):5635\u20135652 e5629","journal-title":"Cell"},{"issue":"1","key":"12771_CR55","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/s41467-021-25928-2","volume":"12","author":"M Song","year":"2021","unstructured":"Song M, Lim JM, Min S, Oh J-S, Kim DY, Woo J-S, Nishimasu H, Cho S-R, Yoon S, Kim HH (2021) Generation of a more efficient prime editor 2 by addition of the Rad51 DNA-binding domain. Nat Commun 12(1):5617","journal-title":"Nat Commun"},{"issue":"5","key":"12771_CR56","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41587-021-01133-w","volume":"40","author":"AV Anzalone","year":"2022","unstructured":"Anzalone AV, Gao XD, Podracky CJ, Nelson AT, Koblan LW, Raguram A, Levy JM, Mercer JA, Liu DR (2022) Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nat Biotechnol 40(5):731\u2013740","journal-title":"Nat Biotechnol"},{"issue":"7","key":"12771_CR57","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/v13071288","volume":"13","author":"W Dong","year":"2021","unstructured":"Dong W, Kantor B (2021) Lentiviral vectors for delivery of gene-editing systems based on CRISPR\/Cas: current state and perspectives. Viruses 13(7):1288","journal-title":"Viruses"},{"issue":"5","key":"12771_CR58","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PW, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discovery 18(5):358\u2013378","journal-title":"Nat Rev Drug Discovery"},{"issue":"2","key":"12771_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41434-018-0003-1","volume":"25","author":"CJ Stephens","year":"2018","unstructured":"Stephens CJ, Kashentseva E, Everett W, Kaliberova L, Curiel DT (2018) Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR\/Cas9. Gene Ther 25(2):139\u2013156","journal-title":"Gene Ther"},{"key":"12771_CR60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","volume":"342","author":"EA Taha","year":"2022","unstructured":"Taha EA, Lee J, Hotta A (2022) Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges. J Controlled Release 342:345\u2013361","journal-title":"J Controlled Release"},{"issue":"4","key":"12771_CR61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ (2020) Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat Nanotechnol 15(4):313\u2013320","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"12771_CR62","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/17425247.2022.2075846","volume":"19","author":"B Costa","year":"2022","unstructured":"Costa B, Boueri B, Oliveira C, Silveira I, Ribeiro AJ (2022) Lipoplexes and polyplexes as nucleic acids delivery nanosystems: The current state and future considerations. Expert Opin Drug Deliv 19(5):577\u2013594","journal-title":"Expert Opin Drug Deliv"},{"key":"12771_CR63","doi-asserted-by":"publisher","first-page":"673286","DOI":"10.3389\/fgene.2021.673286","volume":"12","author":"L Duan","year":"2021","unstructured":"Duan L, Ouyang K, Xu X, Xu L, Wen C, Zhou X, Qin Z, Xu Z, Sun W, Liang Y (2021) Nanoparticle delivery of CRISPR\/Cas9 for genome editing. Front Genet 12:673286","journal-title":"Front Genet"},{"key":"12771_CR64","doi-asserted-by":"crossref","unstructured":"Gagat M, Zieli\u0144ska W, Grzanka (2017) A Cell-penetrating peptides and their utility in genome function modifications. Int J Mol Med 2017, 40(6):1615\u20131623","DOI":"10.3892\/ijmm.2017.3172"},{"issue":"1","key":"12771_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/71889","volume":"18","author":"D Luo","year":"2000","unstructured":"Luo D, Saltzman WM (2000) Synthetic DNA delivery systems. Nat Biotechnol 18(1):33\u201337","journal-title":"Nat Biotechnol"},{"issue":"4","key":"12771_CR66","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.stemcr.2021.02.013","volume":"16","author":"A Kagita","year":"2021","unstructured":"Kagita A, Lung MS, Xu H, Kita Y, Sasakawa N, Iguchi T, Ono M, Wang XH, Gee P, Hotta A (2021) Efficient ssODN-mediated targeting by avoiding cellular inhibitory RNAs through precomplexed CRISPR-Cas9\/sgRNA ribonucleoprotein. Stem Cell Rep 16(4):985\u2013996","journal-title":"Stem Cell Rep"},{"key":"12771_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.addr.2013.11.008","volume":"72","author":"I Lentacker","year":"2014","unstructured":"Lentacker I, De Cock I, Deckers R, De Smedt S, Moonen C (2014) Understanding ultrasound induced sonoporation: definitions and underlying mechanisms. Adv Drug Deliv Rev 72:49\u201364","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"12771_CR68","doi-asserted-by":"publisher","first-page":"e1009117","DOI":"10.1371\/journal.ppat.1009117","volume":"17","author":"E Akidil","year":"2021","unstructured":"Akidil E, Albanese M, Buschle A, Ruhle A, Pich D, Keppler OT, Hammerschmidt W (2021) Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection. PLoS Pathog 17(4):e1009117","journal-title":"PLoS Pathog"},{"issue":"5","key":"12771_CR69","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","volume":"15","author":"PK Mandal","year":"2014","unstructured":"Mandal PK, Ferreira LM, Collins R, Meissner TB, Boutwell CL, Friesen M, Vrbanac V, Garrison BS, Stortchevoi A, Bryder D (2014) Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9. Cell Stem Cell 15(5):643\u2013652","journal-title":"Cell Stem Cell"},{"issue":"33","key":"12771_CR70","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1073\/pnas.1512503112","volume":"112","author":"K Schumann","year":"2015","unstructured":"Schumann K, Lin S, Boyer E, Simeonov DR, Subramaniam M, Gate RE, Haliburton GE, Ye CJ, Bluestone JA, Doudna JA (2015) Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci 112(33):10437\u201310442","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"12771_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J, Mournetas V, Massourid\u00e8s E, Sohier TJ, Corbin A (2019) Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat Commun 10(1):45","journal-title":"Nat Commun"},{"issue":"1","key":"12771_CR72","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1038\/s41467-021-22651-w","volume":"12","author":"RJ Bevacqua","year":"2021","unstructured":"Bevacqua RJ, Dai X, Lam JY, Gu X, Friedlander MS, Tellez K, Miguel-Escalada I, Bon\u00e0s-Guarch S, Atla G, Zhao W (2021) CRISPR-based genome editing in primary human pancreatic islet cells. Nat Commun 12(1):2397","journal-title":"Nat Commun"},{"issue":"2","key":"12771_CR73","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41587-023-01756-1","volume":"42","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Baxter AE, Ren D, Qin K, Chen Z, Collins SM, Huang H, Komar CA, Bailer PF, Parker JB (2024) Efficient engineering of human and mouse primary cells using peptide-assisted genome editing. Nat Biotechnol 42(2):305\u2013315","journal-title":"Nat Biotechnol"},{"issue":"3","key":"12771_CR74","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41587-023-01779-8","volume":"42","author":"AG Allen","year":"2024","unstructured":"Allen AG, Khan SQ, Margulies CM, Viswanathan R, Lele S, Blaha L, Scott SN, Izzo KM, Gerew A, Pattali R (2024) A highly efficient transgene knock-in technology in clinically relevant cell types. Nat Biotechnol 42(3):458\u2013469","journal-title":"Nat Biotechnol"},{"issue":"9","key":"12771_CR75","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41587-022-01639-x","volume":"41","author":"X Dai","year":"2023","unstructured":"Dai X, Park JJ, Du Y, Na Z, Lam SZ, Chow RD, Renauer PA, Gu J, Xin S, Chu Z (2023) Massively parallel knock-in engineering of human T cells. Nat Biotechnol 41(9):1239\u20131255","journal-title":"Nat Biotechnol"},{"issue":"5909","key":"12771_CR76","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1126\/science.1165409","volume":"322","author":"VG Sankaran","year":"2008","unstructured":"Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, Mikkola HK, Hirschhorn JN, Cantor AB, Orkin SH (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322(5909):1839\u20131842","journal-title":"Science"},{"key":"12771_CR77","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ejphar.2019.04.042","volume":"854","author":"MA Khosravi","year":"2019","unstructured":"Khosravi MA, Abbasalipour M, Concordet J-P, Vom Berg J, Zeinali S, Arashkia A, Azadmanesh K, Buch T, Karimipoor M (2019) Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. Eur J Pharmacol 854:398\u2013405","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"12771_CR78","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMoa1609677","volume":"376","author":"J-A Ribeil","year":"2017","unstructured":"Ribeil J-A, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, Caccavelli L, Neven B, Bourget P, El Nemer W (2017) Gene therapy in a patient with sickle cell disease. N Engl J Med 376(9):848\u2013855","journal-title":"N Engl J Med"},{"issue":"9","key":"12771_CR79","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1097\/MS9.0000000000002409","volume":"86","author":"ZS Rahmat","year":"2024","unstructured":"Rahmat ZS, Ali MH, Talha M, Al Hasibuzzaman M (2024) FDA approval of Casgevy and Lyfgenia: a dual breakthrough in gene therapies for sickle cell disease. Annals Med Surg 86(9):4966\u20134968","journal-title":"Annals Med Surg"},{"issue":"4","key":"12771_CR80","first-page":"301","volume":"17","author":"TW Wong","year":"2017","unstructured":"Wong TW, Cohn RD (2017) Therapeutic applications of CRISPR\/Cas for Duchenne muscular dystrophy. Curr Gene Ther 17(4):301\u2013308","journal-title":"Curr Gene Ther"},{"issue":"3","key":"12771_CR81","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson CE, Wu Y, Gemberling MP, Oliver ML, Waller MA, Bohning JD, Robinson-Hamm JN, Bulaklak K, Castellanos Rivera RM, Collier JH (2019) Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat Med 25(3):427\u2013432","journal-title":"Nat Med"},{"issue":"6","key":"12771_CR82","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nbt.4148","volume":"36","author":"S-M Ryu","year":"2018","unstructured":"Ryu S-M, Koo T, Kim K, Lim K, Baek G, Kim S-T, Kim HS, Kim D-e, Lee H, Chung E (2018) Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat Biotechnol 36(6):536\u2013539","journal-title":"Nat Biotechnol"},{"key":"12771_CR83","first-page":"412","volume":"18","author":"S Yzer","year":"2012","unstructured":"Yzer S, den Hollander AI, Lopez I, Pott J-WR, de Faber JTH, Cremers FP, Koenekoop RK, van den Born LI (2012) Ocular and extra-ocular features of patients with Leber congenital amaurosis and mutations in CEP290. Mol Vis 18:412","journal-title":"Mol Vis"},{"issue":"2","key":"12771_CR84","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder ML, Stefanidakis M, Wilson CJ, Baral R, Barrera LA, Bounoutas GS, Bumcrot D, Chao H, Ciulla DM, DaSilva JA (2019) Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat Med 25(2):229\u2013233","journal-title":"Nat Med"},{"issue":"1","key":"12771_CR85","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2015","unstructured":"Cutting GR (2015) Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 16(1):45\u201356","journal-title":"Nat Rev Genet"},{"issue":"9","key":"12771_CR86","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1089\/hum.2019.074","volume":"30","author":"ZP Zhou","year":"2019","unstructured":"Zhou ZP, Yang LL, Cao H, Chen ZR, Zhang Y, Wen X-Y, Hu J (2019) In vitro validation of a CRISPR-mediated CFTR correction strategy for preclinical translation in pigs. Hum Gene Ther 30(9):1101\u20131116","journal-title":"Hum Gene Ther"},{"issue":"6","key":"12771_CR87","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.ymthe.2023.03.004","volume":"31","author":"S Amistadi","year":"2023","unstructured":"Amistadi S, Maule G, Ciciani M, Ensinck MM, De Keersmaecker L, Ramalho AS, Guidone D, Buccirossi M, Galietta LJ, Carlon MS (2023) Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor. Mol Ther 31(6):1647\u20131660","journal-title":"Mol Ther"},{"issue":"5","key":"12771_CR88","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ajpath.2020.01.009","volume":"190","author":"A McCarron","year":"2020","unstructured":"McCarron A, Cmielewski P, Reyne N, McIntyre C, Finnie J, Craig F, Rout-Pitt N, Delhove J, Schjenken JE, Chan HY (2020) Phenotypic characterization and comparison of cystic fibrosis rat models generated using CRISPR\/Cas9 gene editing. Am J Pathol 190(5):977\u2013993","journal-title":"Am J Pathol"},{"issue":"19\u201320","key":"12771_CR89","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1089\/hum.2022.036","volume":"33","author":"Z Yan","year":"2022","unstructured":"Yan Z, Vorhies K, Feng Z, Park SY, Choi SH, Zhang Y, Winter M, Sun X, Engelhardt JF (2022) Recombinant adeno-associated virus-mediated editing of the G551D cystic fibrosis transmembrane conductance regulator mutation in ferret airway basal cells. Hum Gene Ther 33(19\u201320):1023\u20131036","journal-title":"Hum Gene Ther"},{"key":"12771_CR90","doi-asserted-by":"crossref","unstructured":"Nicosia L, Harrison PT (2025) CRISPR for Cystic Fibrosis: advances and insights from a systematic review. Mol Ther 33(9):4091-4112","DOI":"10.1016\/j.ymthe.2025.06.021"},{"issue":"9","key":"12771_CR91","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s42255-020-0254-1","volume":"2","author":"EP Cai","year":"2020","unstructured":"Cai EP, Ishikawa Y, Zhang W, Leite NC, Li J, Hou S, Kiaf B, Hollister-Lock J, Yilmaz NK, Schiffer CA (2020) Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes. Nat metabolism 2(9):934\u2013945","journal-title":"Nat metabolism"},{"issue":"F","key":"12771_CR92","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3889\/oamjms.2021.7658","volume":"9","author":"A Baraja","year":"2021","unstructured":"Baraja A, Sunarto FR, Adji AS, Handajani F, Rahman FS (2021) Deletion of the RNLS gene using CRISPR\/Cas9 as pancreatic cell \u03b2 protection against autoimmune and ER stress for type 1 diabetes mellitus. Open Access Macedonian J Med Sci 9(F):613\u2013619","journal-title":"Open Access Macedonian J Med Sci"},{"issue":"558","key":"12771_CR93","doi-asserted-by":"publisher","first-page":"eaaz8664","DOI":"10.1126\/scitranslmed.aaz8664","volume":"12","author":"C-H Wang","year":"2020","unstructured":"Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LO, Shamsi F, Darcy J, Greenwood BP (2020) CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Sci Transl Med 12(558):eaaz8664","journal-title":"Sci Transl Med"},{"issue":"1","key":"12771_CR94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1172\/JCI26040","volume":"116","author":"AM Powelka","year":"2006","unstructured":"Powelka AM, Seth A, Virbasius JV, Kiskinis E, Nicoloro SM, Guilherme A, Tang X, Straubhaar J, Cherniack AD, Parker MG (2006) Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Investig 116(1):125\u2013136","journal-title":"J Clin Investig"},{"issue":"44","key":"12771_CR95","doi-asserted-by":"publisher","first-page":"17291","DOI":"10.1074\/jbc.RA118.004554","volume":"293","author":"Y Shen","year":"2018","unstructured":"Shen Y, Cohen JL, Nicoloro SM, Kelly M, Yenilmez B, Henriques F, Tsagkaraki E, Edwards YJ, Hu X, Friedline RH (2018) CRISPR-delivery particles targeting nuclear receptor\u2013interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure. J Biol Chem 293(44):17291\u201317305","journal-title":"J Biol Chem"},{"issue":"2","key":"12771_CR96","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1021\/acsnano.7b07874","volume":"12","author":"Y-L Luo","year":"2018","unstructured":"Luo Y-L, Xu C-F, Li H-J, Cao Z-T, Liu J, Wang J-L, Du X-J, Yang X-Z, Gu Z, Wang J (2018) Macrophage-specific in vivo gene editing using cationic lipid-assisted polymeric nanoparticles. ACS Nano 12(2):994\u20131005","journal-title":"ACS Nano"},{"issue":"15","key":"12771_CR97","doi-asserted-by":"publisher","first-page":"8129","DOI":"10.3390\/ijms22158129","volume":"22","author":"M Matboli","year":"2021","unstructured":"Matboli M, Kamel MM, Essawy N, Bekhit MM, Abdulrahman B, Mohamed GF, Eissa S (2021) Identification of novel insulin resistance related ceRNA network in T2DM and its potential editing by CRISPR\/Cas9. Int J Mol Sci 22(15):8129","journal-title":"Int J Mol Sci"},{"issue":"540","key":"12771_CR98","doi-asserted-by":"publisher","first-page":"eaax9106","DOI":"10.1126\/scitranslmed.aax9106","volume":"12","author":"KG Maxwell","year":"2020","unstructured":"Maxwell KG, Augsornworawat P, Velazco-Cruz L, Kim MH, Asada R, Hogrebe NJ, Morikawa S, Urano F, Millman JR (2020) Gene-edited human stem cell\u2013derived \u03b2 cells from a patient with monogenic diabetes reverse preexisting diabetes in mice. Sci Transl Med 12(540):eaax9106","journal-title":"Sci Transl Med"},{"issue":"1","key":"12771_CR99","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1038\/s41467-021-22932-4","volume":"12","author":"C Hunt","year":"2021","unstructured":"Hunt C, Hartford SA, White D, Pefanis E, Hanna T, Herman C, Wiley J, Brown H, Su Q, Xin Y (2021) Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in mice. Nat Commun 12(1):2770","journal-title":"Nat Commun"},{"issue":"4","key":"12771_CR100","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","volume":"24","author":"G Schiroli","year":"2019","unstructured":"Schiroli G, Conti A, Ferrari S, Della Volpe L, Jacob A, Albano L, Beretta S, Calabria A, Vavassori V, Gasparini P (2019) Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response. Cell Stem Cell 24(4):551\u2013565 e558","journal-title":"Cell Stem Cell"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12771-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:02:45Z","timestamp":1789732965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12771-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12771"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12771-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a review research study and is exempt from institutional review board approval.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1589"}}